Page last updated: 2024-11-02

pantoprazole and Lymphoma of Mucosa-Associated Lymphoid Tissue

pantoprazole has been researched along with Lymphoma of Mucosa-Associated Lymphoid Tissue in 2 studies

Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pai, RK1
Snider, WK1
Starkey, CR1
Viswanatha, D1
Foucar, MK1
Wilson, CS1
Wöhrer, S1
Bartsch, R1
Hejna, M1
Drach, J1
Raderer, M1

Other Studies

2 other studies available for pantoprazole and Lymphoma of Mucosa-Associated Lymphoid Tissue

ArticleYear
Nonsecretory variant of immunoproliferative small intestinal disease: a case report with pathologic, immunophenotypic, and molecular findings.
    Archives of pathology & laboratory medicine, 2005, Volume: 129, Issue:11

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Benzimidazoles;

2005
Routine application of the proton-pump inhibitor pantoprazole in patients with gastric lymphoma undergoing chemotherapy.
    Scandinavian journal of gastroenterology, 2005, Volume: 40, Issue:10

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-

2005